2013-2028 Report on Global Drugs for Schistosomiasis Market by Player, Region, Type, Application and Sales Channel

Published: Nov, 2018 | Pages: 101 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Drugs for Schistosomiasis market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for Drugs for Schistosomiasis from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Drugs for Schistosomiasis market.

Leading players of Drugs for Schistosomiasis including:

•	Shin Poong
•	Merck
•	Bayer
•	EIPICO
•	Chandra Bhagat Pharma
•	Taj Pharmaceuticals

Market split by Type, can be divided into:

•	Praziquantel
•	Oxamniquine
•	Other

Market split by Application, can be divided into:

•	S. haematobium
•	S. mansoni
•	S. japonicum
•	S. mekongi
•	S. intercalatum

Market split by Sales Channel, can be divided into:

•	Direct Channel
•	Distribution Channel

Market segment by Region/Country including:

•	North America (United States, Canada and Mexico)
•	Europe (Germany, UK, France, Italy, Russia and Spain etc.)
•	Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
•	South America Brazil, Argentina, Colombia and Chile etc.)
•	Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Drugs for Schistosomiasis Market Overview
    1.1 Drugs for Schistosomiasis Definition
    1.2 Global Drugs for Schistosomiasis Market Size Status and Outlook (2013-2028)
    1.3 Global Drugs for Schistosomiasis Market Size Comparison by Region (2013-2028)
    1.4 Global Drugs for Schistosomiasis Market Size Comparison by Type (2013-2028)
    1.5 Global Drugs for Schistosomiasis Market Size Comparison by Application (2013-2028)
    1.6 Global Drugs for Schistosomiasis Market Size Comparison by Sales Channel (2013-2028)
    1.7 Drugs for Schistosomiasis Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Drugs for Schistosomiasis Market Segment Analysis by Player
    2.1 Global Drugs for Schistosomiasis Sales and Market Share by Player (2016-2018)
    2.2 Global Drugs for Schistosomiasis Revenue and Market Share by Player (2016-2018)
    2.3 Global Drugs for Schistosomiasis Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player

Chapter 3 Drugs for Schistosomiasis Market Segment Analysis by Type
    3.1 Global Drugs for Schistosomiasis Market by Type
        3.1.1 Praziquantel
        3.1.2 Oxamniquine
        3.1.3 Other
    3.2 Global Drugs for Schistosomiasis Sales and Market Share by Type (2013-2018)
    3.3 Global Drugs for Schistosomiasis Revenue and Market Share by Type (2013-2018)
    3.4 Global Drugs for Schistosomiasis Average Price by Type (2013-2018)
    3.5 Leading Players of Drugs for Schistosomiasis by Type in 2017
    3.6 Conclusion of Segment by Type

Chapter 4 Drugs for Schistosomiasis Market Segment Analysis by Application
    4.1 Global Drugs for Schistosomiasis Market by Application
        4.1.1 S. haematobium
        4.1.2 S. mansoni
        4.1.3 S. japonicum
        4.1.4 S. mekongi
        4.1.5 S. intercalatum
    4.2 Global Drugs for Schistosomiasis Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Drugs for Schistosomiasis by Application in 2017
    4.4 Conclusion of Segment by Application

Chapter 5 Drugs for Schistosomiasis Market Segment Analysis by Sales Channel
    5.1 Global Drugs for Schistosomiasis Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Drugs for Schistosomiasis Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Drugs for Schistosomiasis by Sales Channel in 2017
    5.4 Conclusion of Segment by Sales Channel

Chapter 6 Drugs for Schistosomiasis Market Segment Analysis by Region
    6.1 Global Drugs for Schistosomiasis Market Size and CAGR by Region (2013-2028)
    6.2 Global Drugs for Schistosomiasis Sales and Market Share by Region (2013-2018)
    6.3 Global Drugs for Schistosomiasis Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Drugs for Schistosomiasis Market Share by Type
        6.4.3 North America Drugs for Schistosomiasis Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Drugs for Schistosomiasis Market Share by Type
        6.5.3 Europe Drugs for Schistosomiasis Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Drugs for Schistosomiasis Market Share by Type
        6.6.3 Asia-Pacific Drugs for Schistosomiasis Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Drugs for Schistosomiasis Market Share by Type in 2017
        6.7.3 South America Drugs for Schistosomiasis Market Share by Application in 2017
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Drugs for Schistosomiasis Market Share by Type
        6.8.3 Middle East & Africa Drugs for Schistosomiasis Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Drugs for Schistosomiasis Players
    7.1 Shin Poong
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Merck
    7.3 Bayer
    7.4 EIPICO
    7.5 Chandra Bhagat Pharma
    7.6 Taj Pharmaceuticals

Chapter 8 Upstream and Downstream Analysis of Drugs for Schistosomiasis
    8.1 Industrial Chain of Drugs for Schistosomiasis
    8.2 Upstream of Drugs for Schistosomiasis
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Drugs for Schistosomiasis
        8.3.1 Leading Distributors/Dealers of Drugs for Schistosomiasis
        8.3.2 Leading Consumers of Drugs for Schistosomiasis

Chapter 9 Development Trend of Drugs for Schistosomiasis (2018-2028)
    9.1 Global Drugs for Schistosomiasis Market Size (Sales and Revenue) Forecast (2018-2028)
    9.2 Global Drugs for Schistosomiasis Market Size and CAGR Forecast by Region (2018-2028)
    9.3 Global Drugs for Schistosomiasis Market Size and CAGR Forecast by Type (2018-2028)
    9.4 Global Drugs for Schistosomiasis Market Size and CAGR Forecast by Application (2018-2028)
    9.5 Global Drugs for Schistosomiasis Market Size Forecast by Sales Channel (2018-2028)

Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Drugs for Schistosomiasis Example
    Figure Global Drugs for Schistosomiasis Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Drugs for Schistosomiasis Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Drugs for Schistosomiasis Sales Comparison by Type (2013-2028)
    Figure Global Drugs for Schistosomiasis Sales Comparison by Application (2013-2028)
    Figure Global Drugs for Schistosomiasis Sales Comparison by Sales Channel (2013-2028)
    Table Global Drugs for Schistosomiasis Sales by Player (2016-2018)
    Table Global Drugs for Schistosomiasis Sales Market Share by Player (2016-2018)
    Figure Global Drugs for Schistosomiasis Sales Market Share by Player in 2017
    Table Global Drugs for Schistosomiasis Revenue (Million $) by Player (2016-2018)
    Table Global Drugs for Schistosomiasis Revenue Market Share by Player (2016-2018)
    Figure Global Drugs for Schistosomiasis Revenue Market Share by Player in 2017
    Table Global Drugs for Schistosomiasis Average Price by Player (2016-2018)
    Figure Global Drugs for Schistosomiasis Average Price by Player in 2017
    Figure Global Drugs for Schistosomiasis Players Competition Situation - Top 5 Players' Revenue Market Share in 2017
    Figure Global Drugs for Schistosomiasis Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Praziquantel
    Figure Global Praziquantel Sales and Growth Rate (2013-2018)
    Figure Example of Oxamniquine
    Figure Global Oxamniquine Sales and Growth Rate (2013-2018)
    Figure Example of Other
    Figure Global Other Sales and Growth Rate (2013-2018)
    Table Global Drugs for Schistosomiasis Sales by Type (2013-2018)
    Table Global Drugs for Schistosomiasis Sales Market Share by Type (2013-2018)
    Figure Global Drugs for Schistosomiasis Sales Market Share by Type in 2017
    Table Global Drugs for Schistosomiasis Revenue (Million $) by Type (2013-2018)
    Table Global Drugs for Schistosomiasis Revenue Market Share by Type (2013-2018)
    Figure Global Drugs for Schistosomiasis Revenue Market Share by Type in 2017
    Table Global Drugs for Schistosomiasis Average Price by Type (2013-2018)
    Figure Global Drugs for Schistosomiasis Average Price by Type in 2017
    Table Leading Players of Drugs for Schistosomiasis by Type in 2017
    Figure Example of S. haematobium
    Figure Global Drugs for Schistosomiasis for S. haematobium Sales and Growth Rate (2013-2018)
    Figure Example of S. mansoni
    Figure Global Drugs for Schistosomiasis for S. mansoni Sales and Growth Rate (2013-2018)
    Figure Example of S. japonicum
    Figure Global Drugs for Schistosomiasis for S. japonicum Sales and Growth Rate (2013-2018)
    Figure Example of S. mekongi
    Figure Global Drugs for Schistosomiasis for S. mekongi Sales and Growth Rate (2013-2018)
    Figure Example of S. intercalatum
    Figure Global Drugs for Schistosomiasis for S. intercalatum Sales and Growth Rate (2013-2018)
    Table Global Drugs for Schistosomiasis Sales by Application (2013-2018)
    Table Global Drugs for Schistosomiasis Sales Market Share by Application (2013-2018)
    Figure Global Drugs for Schistosomiasis Sales Market Share by Application in 2017
    Table Leading Consumers of Drugs for Schistosomiasis by Application in 2017
    Figure Example of Direct Channel
    Figure Global Drugs for Schistosomiasis for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Drugs for Schistosomiasis for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Drugs for Schistosomiasis Sales by Sales Channel (2013-2018)
    Table Global Drugs for Schistosomiasis Sales Market Share by Sales Channel (2013-2018)
    Figure Global Drugs for Schistosomiasis Sales Market Share by Sales Channel in 2017
    Table Leading Distributors/Dealers of Drugs for Schistosomiasis by Sales Channel in 2017
    Table Global Drugs for Schistosomiasis Market Size and CAGR by Region (2013-2028)
    Table Global Drugs for Schistosomiasis Sales by Region (2013-2018)
    Table Global Drugs for Schistosomiasis Sales Market Share by Region (2013-2018)
    Figure Global Drugs for Schistosomiasis Sales Market Share by Region in 2017
    Table Global Drugs for Schistosomiasis Revenue (Million $) by Region (2013-2018)
    Table Global Drugs for Schistosomiasis Revenue Market Share by Region (2013-2018)
    Figure Global Drugs for Schistosomiasis Revenue Market Share by Region in 2017
    Table North America Drugs for Schistosomiasis Sales by Country (2013-2018)
    Figure North America Drugs for Schistosomiasis Sales Market Share by Country (2013-2018)
    Table North America Drugs for Schistosomiasis Revenue by Country (2013-2018)
    Figure North America Drugs for Schistosomiasis Revenue Market Share by Country (2013-2018)
    Figure North America Drugs for Schistosomiasis Sales Market Share by Type in 2017
    Figure North America Drugs for Schistosomiasis Sales Market Share by Application in 2017
    Figure United States Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure United States Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Canada Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Mexico Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Drugs for Schistosomiasis Sales by Country (2013-2018)
    Figure Europe Drugs for Schistosomiasis Sales Market Share by Country (2013-2018)
    Table Europe Drugs for Schistosomiasis Revenue by Country (2013-2018)
    Figure Europe Drugs for Schistosomiasis Revenue Market Share by Country (2013-2018)
    Figure Europe Drugs for Schistosomiasis Sales Market Share by Type in 2017
    Figure Europe Drugs for Schistosomiasis Sales Market Share by Application in 2017
    Figure Germany Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Germany Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure UK Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure France Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Italy Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Russia Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Spain Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Drugs for Schistosomiasis Sales by Country (2013-2018)
    Figure Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Drugs for Schistosomiasis Revenue by Country (2013-2018)
    Figure Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Type in 2017
    Figure Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Application in 2017
    Figure China Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure China Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Japan Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Korea Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure India Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Australia Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Drugs for Schistosomiasis Sales by Country (2013-2018)
    Figure South America Drugs for Schistosomiasis Sales Market Share by Country (2013-2018)
    Table South America Drugs for Schistosomiasis Revenue by Country (2013-2018)
    Figure South America Drugs for Schistosomiasis Revenue Market Share by Country (2013-2018)
    Figure South America Drugs for Schistosomiasis Sales Market Share by Type in 2017
    Figure South America Drugs for Schistosomiasis Sales Market Share by Application in 2017
    Figure Brazil Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Brazil Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Argentina Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Colombia Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Chile Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Drugs for Schistosomiasis Sales by Country (2013-2018)
    Figure Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Drugs for Schistosomiasis Revenue by Country (2013-2018)
    Figure Middle East & Africa Drugs for Schistosomiasis Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Type in 2017
    Figure Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Application in 2017
    Figure Egypt Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Egypt Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure South Africa Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Drugs for Schistosomiasis Sales and Growth Rate (2013-2018)
    Figure Nigeria Drugs for Schistosomiasis Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Shin Poong
    Table Drugs for Schistosomiasis Introduction of Shin Poong
    Table Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share of Shin Poong (2016-2018)
    Table Industrial Chain of Drugs for Schistosomiasis
    Table Manufacturing Cost Structure of Drugs for Schistosomiasis
    Table General Manufacturing Process of Drugs for Schistosomiasis
    Table Leading Distributors/Dealers of Drugs for Schistosomiasis
    Table Leading Consumers of Drugs for Schistosomiasis
    Figure Global Drugs for Schistosomiasis Sales and Growth Rate Forecast (2018-2028)
    Figure Global Drugs for Schistosomiasis Revenue and Growth Rate Forecast (2018-2028)
    Table Global Drugs for Schistosomiasis Market Size and CAGR Forecast by Region (2018-2028)
    Table Global Drugs for Schistosomiasis Market Size and CAGR Forecast by Type (2018-2028)
    Table Global Drugs for Schistosomiasis Market Size and CAGR Forecast by Application (2018-2028)
    Table Global Drugs for Schistosomiasis Market Size and CAGR Forecast by Sales Channel (2018-2028)